and significantly (p<0,01) increased activity of glutathione reductase (83,43± 15,25 U/g Hb and 65,74 ± 14,27 U/g Hb, respectively).
1.
Introduction The oxidative hypothesis of senescence has been introduced in 1956 by Harman and has become one of the most prolific theories of aging since its origin [1, 2] . This agerelated oxidative stress is generated by a combination of increased production of free radicals, decreased antioxidants levels, diminished activity of antioxidant enzymes and impaired repair of oxidative damages. There are many physiological processes in the human body which generate reactive oxygen species (ROS) which due to their unstability and high reactivity are harmful for the cells. To protect themselves from ROS, cells are equipped with antioxidant enzymes i.e. superoxide dismutase (SOD) catalyzes dismutation of O2 •-, catalase (CAT) scavenges H2O2, glutathione peroxidase (GPx) converts H2O2 to water and neutralizes lipid peroxyl radials. Glutathione serves as a major thioldisulfide redox buffer of the cell and its reduced form pool is maintained by glutathione reductase (GR). When oxidants are produced in excess and overwhelm the cellular antioxidant capacity the state of oxidative stress occurs. This can result in molecular and cellular tissue damage as well as in severe metabolic malfunctions caused by oxygen radical-mediated toxicity [3] . It has been established taht O2 •-, H2O2 and ONOO -which is formed in radicalradical coupling reactions, play an important role in the development of hypertension due to their effect on vascular tone [4] (Fig.1) . Lower concentration of GSH in DM group when compared to HT group, was accompanied by decreased activity of GR (Fig. 2) . Mean enzyme activity was significantly lower in diabetics (p<0,01) than in hypertensives. GR exhibited activities of 63,8 ± 15,15 U/g Hb and 83,4± 15,25 U/g Hb in DM and HT groups, respectively. We have also measured GPx activity, however no significant differences between analysed groups were discovered in this case. Activity of GPx1 was as high as 12,76 ± 2,65 U/g Hb and 13,16 ± 1,95 U/g Hb in patients treated for diabetes and for hypertension, respectively which again follows the pattern of decreased antioxidants in diabetes mellitus type II patients in comparison to hypertensive patients in our study. Altogether this results suggest that diabetes mellitus type II and essential hypertension which both has been proven to be associated with oxidative stress may differ regarding to mechanisms implicating oxidative stress in their pathogenesis as well as response to medical treatment. 
Discussion
Results from this research suggest significantly decreased level of glutathione (GSH) in treated diabetes type II elderly subjects when compared with these treated for hypertension. Majority of studies reveal decrease of GSH in pathological conditions analysed [9,10] but we can not conclude it from the data presented herein still we have not compared the result of patients from our groups with healthy controls at the same age. However we have done similar study before and interestingly when parallelly analyzed the same parameters in controls we observed that patients with treated hypertension had significantly higher GSH concentration than subjects from two other groups which have had similar level of GSH. The explanation of this phenomenon may be that antioxidant thiols concentration increase due to higher concentration of ROS which means that hypertensives are more volnurable to oxidative stress. Glutathione deficiency contributes to oxidative stress, which plays important role in aging and the pathogenesis of many diseases such as diabetes and cardiovascular diseases [11, 12] . On the other hand higher level of reduced glutathione can be considered as better protection against oxidative stress since protective role of glutathione against oxidative stress among other important functions has been recognized [13] .
In order to better understand the mechanisms of GSH increase in hypertension the values of other parameters of oxidative stress and antioxidant defense need to be taken into account as well as the fact that important confounder in our study was the medication. Antihypertensive drugs are indeed proven to have antioxidant properties [14, 15, 16, 17, 18] . Since hypertensive patients received different antihypertensive drugs with various combinations in this group we could look for the complete status of antihypertensive drugs effect over oxidative stress alone.
The relation between oxidative stress and blood pressure is explained through inactivation of the vasodilator nitric oxide (NO)
by ROS and formation of peroxynitrite ONOO [15] . GSH plays important role in maintenance of NO pool. GSH reacts with peroxynitrite to produce Snitrosoglutathione (GSNO) which extends the half-life of NO and in consequence contributes in relaxation of vascular tissue [20] . GSH enhances decomposition of nitrosothiols and release of NO [21] . Moreover nitrosothiols have the ability to inhibit NADPH oxidase and therefore have beneficial effect on vascular tension. Other important role of GSH is control of PDGFmediated ROS production by NADH/NADPH oxidase which is considered to be the main source of vascular ROS [5, 15, 22] . Well-established role of GSH is reduction of hydrogen peroxide in the presence of GPx Reduced form of glutathione is restored by glutathione reductase (GR) [13] . In our study GPx1 activity has not differed significantly while comparing two examined groups. Results of other studies concerning GPx activity in HT subjects are contradictory showing both increased and decreased activity of the enzyme [23] . The same conclusion can be made regarding review of diabetes mellitus studies [ 24, 25] . Although GPx1 remained unchanged, GR activity increased significantly in HT group. This observation has been interrelated with GSH concentration analyses. We assumed that elevated level of glutathione is the result of increased activity of GR. However, this parameters are not significantly correlated in our study. Protective role of GPx1 in coping with oxidative injury and cell death mediated by reactive oxygen species in vivo has been supported by substantial body of evidence. Among other important functions in coping with oxidative stress GPx possesses the ability to decompose GSNO and is also responsible for lipid hydroperoxides reduction, thereby preventing inactivation of NO [26] . Nevertheless the ability to potentiate reactive nitrogen species stress has been also reported. GPx seems to play contradictory roles in coping with ROS vs. RNS [27] .
Altogether our results suggest that the mechanisms which link oxidative stress with various pathological conditions may differ and may be associated with changes of different parameters depending of the pathogenesis of the condition and furthermore the action of pharmaceutical agents.
